These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 11289469)

  • 1. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
    Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
    Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
    Davidson MB; Schriger DL; Peters AL; Lorber B
    JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
    Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
    BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
    Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
    Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The simultaneous assessment of glycosylated hemoglobin, fasting plasma glucose and oral glucose tolerance test does not improve the detection of type 2 diabetes mellitus in Colombian adults.
    Lopez-Lopez J; Garay J; Wandurraga E; Camacho PA; Higuera-Escalante F; Cohen D; Lopez-Jaramillo P
    PLoS One; 2018; 13(4):e0194446. PubMed ID: 29652881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.
    Ko GT; Chan JC; Tsang LW; Cockram CS
    Diabetes Care; 2000 Dec; 23(12):1770-3. PubMed ID: 11128350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.
    Maynard JD; Rohrscheib M; Way JF; Nguyen CM; Ediger MN
    Diabetes Care; 2007 May; 30(5):1120-4. PubMed ID: 17337498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.
    Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP
    Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.
    Norberg M; Eriksson JW; Lindahl B; Andersson C; Rolandsson O; Stenlund H; Weinehall L
    J Intern Med; 2006 Sep; 260(3):263-71. PubMed ID: 16918824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of HbA1c combined FPG on screening diabetes in health check-up.
    Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
    Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes screening in overweight and obese children and adolescents: choosing the right test.
    Ehehalt S; Wiegand S; Körner A; Schweizer R; Liesenkötter KP; Partsch CJ; Blumenstock G; Spielau U; Denzer C; Ranke MB; Neu A; Binder G; Wabitsch M; Kiess W; Reinehr T
    Eur J Pediatr; 2017 Jan; 176(1):89-97. PubMed ID: 27888412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA₁c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients.
    Hjellestad ID; Astor MC; Nilsen RM; Søfteland E; Jonung T
    Cardiovasc Diabetol; 2013 May; 12():79. PubMed ID: 23705980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HbA1c predicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose.
    Geberhiwot T; Haddon A; Labib M
    Ann Clin Biochem; 2005 May; 42(Pt 3):193-5. PubMed ID: 15949153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosing type 2 diabetes mellitus: in primary care, fasting plasma glucose and glycosylated haemoglobin do the job].
    Jimeno Mollet J; Molist Brunet N; Franch Nadal J; Morató Griera J; Otzet Gramunt I; Pons Barro P
    Aten Primaria; 2004 Sep; 34(5):222-8. PubMed ID: 15456566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
    Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A
    Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.